UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): August 8, 2011
CareFusion Corporation
(Exact Name of Registrant as Specified in its Charter)
Delaware
(State or Other Jurisdiction
of Incorporation)
| | |
| 001-34273 | | 26-4123274 |
(Commission File Number) | | (IRS Employer Identification Number) |
3750 Torrey View Court, San Diego, California 92130
(Address of Principal Executive Offices, Including Zip Code)
(858) 617-2000
(Registrant’s Telephone Number, Including Area Code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (seeGeneral Instruction A.2. below):
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 2.02 | Results of Operations and Financial Condition |
On August 8, 2011, CareFusion Corporation (the “Company”) issued a news release (the “News Release”) announcing its results for the quarter and fiscal year ended June 30, 2011. A copy of the News Release is furnished as Exhibit 99.1 to this report.
A discussion of the reasons why management believes that the presentation of non-GAAP financial measures provides useful information to investors regarding the Company’s financial condition and results of operations is furnished as Exhibit 99.3 to this report.
| Item 7.01 | Regulation FD Disclosure |
During a conference call scheduled to be held at 2:00 p.m. PDT on August 8, 2011, the Company’s Chairman and Chief Executive Officer and Chief Financial Officer will discuss the Company’s results for the quarter and fiscal year ended June 30, 2011 and the outlook for the fiscal year ending June 30, 2012. The slide presentation for the conference call is furnished as Exhibit 99.2 to this report.
| Item 9.01 | Financial Statements and Exhibits |
| | |
Exhibit
No. | | Description of Exhibit |
| |
| 99.1 | | News release issued by CareFusion Corporation on August 8, 2011 reporting earnings results for the quarter and fiscal year ended June 30, 2011* |
| |
| 99.2 | | Slide presentation* |
| |
| 99.3 | | Information disclosed by CareFusion Corporation on August 8, 2011* |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | | | |
| | CareFusion Corporation (Registrant) |
| | |
| Date: August 8, 2011 | | By: | | /s/ Joan Stafslien |
| | | | Name: | | Joan Stafslien |
| | | | Title: | | Executive Vice President, Chief Compliance Officer, General Counsel and Secretary |
EXHIBIT INDEX
| | |
Exhibit
No. | | Description of Exhibit |
| |
| 99.1 | | News release issued by CareFusion Corporation on August 8, 2011 reporting earnings results for the quarter and fiscal year ended June 30, 2011* |
| |
| 99.2 | | Slide presentation* |
| |
| 99.3 | | Information disclosed by CareFusion Corporation on August 8, 2011* |
